| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Article |

From the Neuroinflammation Group,*
Department of
Neurochemistry, Institute of Neurology, University College London,
London, United Kingdom; and the Genetics
Institute,
Andover, Massachusetts
Lewis rats, on recovery from monophasic clinical experimental allergic encephalomyelitis (EAE), can be induced to develop repeated paralytic relapses with a graded reduction in clinical severity following intraperitoneal administration of IL-12. By the time of the third relapse, the number and size of inflammatory cuffs in the spinal cord were reduced with the makeup of the cellular infiltrate shifting to a significantly increased number of B cells. Serum levels of myelin basic protein (MBP)-specific IgG1 and IgG2b were found to rise over time while MBP and MBP peptide-positive macrophages and microglia became evident in perivascular cuffs and in spinal cord parenchyma, indicative of myelin phagocytosis. Axonal death was observed in semithin and EM sections of spinal cord in third relapse animals in association with iNOS and tPA immunostaining throughout gray and white matter. These neurotoxic or excitotoxic agents may contribute to axonal damage directly or indirectly by activated microglia and macrophages, leading to limited damage of the axonal-myelin unit.
This article has been cited by other articles:
![]() |
M. J Nunez, J. Balboa, M. Rey-Mendez, J. Brenlla, M. Gonzalez-Peteiro, E. Rodrigo, and M. Freire-Garabal Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats Human and Experimental Toxicology, August 1, 2007; 26(8): 637 - 643. [Abstract] [PDF] |
||||
![]() |
E. East, D. Baker, G. Pryce, H. R. Lijnen, M. L. Cuzner, and D. Gveric A Role for the Plasminogen Activator System in Inflammation and Neurodegeneration in the Central Nervous System during Experimental Allergic Encephalomyelitis Am. J. Pathol., August 1, 2005; 167(2): 545 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. GROOM, T. SMITH, and L. TURSKI Multiple Sclerosis and Glutamate Ann. N.Y. Acad. Sci., May 1, 2003; 993(1): 229 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. M. Brok, M. van Meurs, E. Blezer, A. Schantz, D. Peritt, G. Treacy, J. D. Laman, J. Bauer, and B. A. 't Hart Prevention of Experimental Autoimmune Encephalomyelitis in Common Marmosets Using an Anti-IL-12p40 Monoclonal Antibody J. Immunol., December 1, 2002; 169(11): 6554 - 6563. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ahmed, A. I. Doward, G. Pryce, D. L. Taylor, J. M. Pocock, J. P. Leonard, D. Baker, and M. L. Cuzner A Role for Caspase-1 and -3 in the Pathology of Experimental Allergic Encephalomyelitis : Inflammation Versus Degeneration Am. J. Pathol., November 1, 2002; 161(5): 1577 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy J. Neurosci., April 1, 2002; 22(7): 2690 - 2700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |